Skip to main content
Equibles

M&G PLC

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 1802539 London, X0
Back to BRNS Full portfolio

Position in BRNS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,430,250
+$472,959 QoQ
Shares Held
5,197,349
0.0% QoQ
Ownership
12.7%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 15 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BRNS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

M&G PLC holds $116,189,172 across 10 Biotechnology names. BRNS ranks #6 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 223,445 $63,675,121
2 AXSM
Axsome Therapeutics, Inc.
 58,976 $14,435,555
3 BMRN
Biomarin Pharmaceutical Inc
 216,096 $12,365,013
4 ALNY
Alnylam Pharmaceuticals, Inc.
 35,912 $10,810,589
5 INSM
INSMED Inc
 88,008 $9,383,412
6 BRNS
Barinthus Biotherapeutics plc.
This page 		5,197,349 $3,430,250
7 RVMD
Revolution Medicines, Inc.
 4,296 $804,554
8 MESO
Mesoblast Ltd
 59,100 $799,623

All Filings in BRNS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,430,250 5,197,349
2026-03-31 $2,957,291 5,197,349
2025-12-31 $3,638,144 5,197,349
2025-09-30 $6,496,686 5,197,349
2025-06-30 $4,833,534 5,197,349
2025-03-31 $5,057,020 5,197,349
2024-12-31 $6,278,397 5,197,349
2024-09-30 $6,184,845 5,197,349
2024-06-30 $7,276,288 5,197,349
2024-03-31 $12,369,690 5,197,349